Sign up to save your podcasts
Or
Share Determining clinically meaningful decline in preclinical Alzheimer disease
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Determining clinically meaningful decline in preclinical Alzheimer disease
Dr. Philip Insel provides the main findings of his paper on determining clinically meaningful decline in preclinical Alzheimer disease.
View all episodes
By American Academy of Neurology
4.8
132132 ratings
Dr. Philip Insel provides the main findings of his paper on determining clinically meaningful decline in preclinical Alzheimer disease.
More shows like Neurology Minute
View all
NEJM This Week
327 Listeners
JAMA Clinical Reviews
500 Listeners
Neurology® Podcast
302 Listeners
Practical Neurology Podcast
55 Listeners
Mayo Clinic Talks
299 Listeners
The Curbsiders Internal Medicine Podcast
3,382 Listeners
JAMA Neurology Author Interviews
14 Listeners
Core IM | Internal Medicine Podcast
1,148 Listeners
Neurology Today in 5
25 Listeners
Annals On Call Podcast
197 Listeners
JAMA Medical News
90 Listeners
The Clinical Problem Solvers
515 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
363 Listeners
Neurology Exam Prep Podcast
187 Listeners
Continuum Audio
82 Listeners